Baylon, Marcializa R.

HRN: 00-96-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2023
CEFUROXIME 1.5GM (VIAL)
02/18/2023
02/18/2023
IVT
1.5gms
Prior To OR
For TAHBSO
Waiting Final Action 
02/18/2023
CEFUROXIME 1.5GM (VIAL)
02/18/2023
02/19/2023
IV
1.5gm
Q8
S/P TAHBSO
Waiting Final Action 
02/19/2023
CEFUROXIME 500MG (TAB)
02/19/2023
02/26/2023
PO
500mg
BID
S/P TAHBSO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: